|
PLEKHG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4432899320127E-15 |
| Normal-vs-Stage2 |
1.021140E-03 |
| Normal-vs-Stage3 |
3.86219999981563E-07 |
| Normal-vs-Stage4 |
1.60285999999399E-05 |
| Stage1-vs-Stage2 |
7.445200E-01 |
| Stage1-vs-Stage3 |
4.284400E-01 |
| Stage1-vs-Stage4 |
8.662400E-01 |
| Stage2-vs-Stage3 |
8.834200E-01 |
| Stage2-vs-Stage4 |
7.067200E-01 |
| Stage3-vs-Stage4 |
5.262200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62592161956354E-12 |
| Normal-vs-AfricanAmerican |
1.062120E-03 |
| Normal-vs-Asian |
1.59550999999647E-05 |
| Caucasian-vs-AfricanAmerican |
4.970000E-01 |
| Caucasian-vs-Asian |
7.107200E-01 |
| AfricanAmerican-vs-Asian |
3.894000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04039998838346E-09 |
| Normal-vs-Female |
2.44249065417534E-15 |
| Male-vs-Female |
7.824800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.21724893790088E-15 |
| Normal-vs-Age(41-60Yrs) |
1.83810000553564E-09 |
| Normal-vs-Age(61-80Yrs) |
2.77390000003042E-06 |
| Normal-vs-Age(81-100Yrs) |
3.274300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.949600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.294020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.883200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.224200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.718200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.487200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.241400E-03 |
| Classical-VS-Follicular |
4.03090000000716E-06 |
| Classical-VS-Other |
2.290200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
6.872400E-01 |
| Tall-VS-Other |
7.998200E-01 |
| Tall-VS-Normal |
8.016300E-04 |
| Follicular-VS-Other |
9.830800E-01 |
| Follicular-VS-Normal |
1.987890E-04 |
| Other-VS-Normal |
2.399000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51650003665793E-09 |
| Normal-vs-N1 |
1.4313999996407E-07 |
| N0-vs-N1 |
4.600400E-02 |
|
|
